An excellent example of translational potential is provided by a recent study in which recombinant adropin demonstrated promising antifibrotic effects in systemic sclerosis, reducing both the number of fibroblasts and collagen production [43]. The gene discussed is ENHO; the disease is systemic sclerosis.